PulseSight Seeks French Approval for Phase I Trial...
Category : Clinical Trial Update 16 January 2025PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vector...
Clinical Trial Update
ImmunoForge Gets FDA, MFDS Approvals for Pemzivipt...
Category : Clinical Trial Update 15 January 2025ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemz...
Nektar Completes Enrollment for REZOLVE-AD Phase 2...
Category : Clinical Trial Update 14 January 2025Nektar Therapeutics, a clinical-stage biotechnology company, announced the company has completed tar...
Crinetics Pharma Reports Positive Phase 2 Results...
Category : Clinical Trial Update 14 January 2025Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, announced positive topline...
ProMIS Neurosciences Starts Phase 1b Trial of PMN3...
Category : Clinical Trial Update 14 January 2025"ProMIS Neurosciences Inc., a clinical-stage biotechnology company focused on developing precis...
Latest Newsletter Post
-
InnoCare, KeyMed Partner with Proli..
22 January 2025
-
FDA Approves Zydus’ Phase IIb trial..
21 January 2025
-
Fermion & Simcere Partner to Develo..
21 January 2025
-
EMA Recommends Bluevac-3 and Syvazu..
21 January 2025
-
Teva Partners with Formycon to Comm..
16 January 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com